Literature DB >> 15821888

Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among HIV-1 infected individuals before and after antiretroviral therapy.

Carmem Beatriz Wagner Giacoia-Gripp1, Ivan Neves, Maria Clara Galhardo, Mariza Gonçalves Morgado.   

Abstract

HIV-1 infection leads to serious impairment of the immune system and perturbations in the T cell receptor Vbeta repertoire are also described. Immune reconstitution can be potentially achieved in response to HAART. In the present study 10 patients were investigated for the Vbeta pattern expression before and after six months of HAART. TCR were analyzed for T CD4+ and CD8+ subsets, separately, by flow cytometry, using a monoclonal antibody set of 24 different Vbeta chains. Compared to eight Brazilian healthy controls, no differences in Vbeta pattern of expression was observed for patients before or on antiretroviral therapy. Some chains such as Vbeta 3, 14, 16, 20 and 21.3 were over utilized by both T subsets, independently of HIV infection and/or antiretroviral treatment, differing from the ones described for individuals of other nationalities. However, when each patient was taken individually, particular alterations were detected for the Vbeta gene usage, compared to controls, for all individuals. After treatment, significant Vbeta usage changes were observed for seven patients. One or more chains on both T subsets were engaged in this process, defining a preferential oligoclonal profile for TCR repertoire distribution, after HAART. Although no pattern of specific Vbeta changes was detected in the circulating T cells, we cannot exclude that differential immune responses to HIV or other important antigens are being focused by these cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821888     DOI: 10.1007/s10875-005-2817-z

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  51 in total

1.  Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.

Authors:  L Al-Harthi; J Siegel; J Spritzler; J Pottage; M Agnoli; A Landay
Journal:  AIDS       Date:  2000-05-05       Impact factor: 4.177

2.  Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes.

Authors:  J Grunewald; C H Janson; H Wigzell
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

Review 3.  The influence of genetics, environment, and disease state on the human T-cell receptor repertoire.

Authors:  J Silver; B Gulwani-Akolkar; P N Akolkar
Journal:  Ann N Y Acad Sci       Date:  1995-07-07       Impact factor: 5.691

Review 4.  Immunopathogenesis of HIV infection.

Authors:  C Graziosi; H Soudeyns; G P Rizzardi; P A Bart; A Chapuis; G Pantaleo
Journal:  AIDS Res Hum Retroviruses       Date:  1998-06       Impact factor: 2.205

5.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

6.  Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy.

Authors:  F Bouscarat; M Levacher; R Landman; M Muffat-Joly; P M Girard; A G Saimot; F Brun-Vézinet; M Sinet
Journal:  AIDS       Date:  1998-07-30       Impact factor: 4.177

7.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.

Authors:  L R Bisset; R W Cone; W Huber; M Battegay; P L Vernazza; R Weber; P J Grob; M Opravil
Journal:  AIDS       Date:  1998-11-12       Impact factor: 4.177

9.  Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

Authors:  A C Collier; R W Coombs; D A Schoenfeld; R L Bassett; J Timpone; A Baruch; M Jones; K Facey; C Whitacre; V J McAuliffe; H M Friedman; T C Merigan; R C Reichman; C Hooper; L Corey
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

10.  T cell receptor (TCR) V gene segment use in HLA-typed Japanese healthy subjects.

Authors:  M Shigematsu; S Nagai; T Mikuniya; T Izumi; H Wigzell; A G Eklund; J Grunewald
Journal:  Clin Exp Immunol       Date:  1996-01       Impact factor: 4.330

View more
  4 in total

1.  CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.

Authors:  T S L Keesen; L R V Antonelli; D R Faria; L H Guimarães; O Bacellar; E M Carvalho; W O Dutra; K J Gollob
Journal:  Clin Exp Immunol       Date:  2011-07-04       Impact factor: 4.330

2.  IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.

Authors:  Souheil-Antoine Younes; Michael L Freeman; Joseph C Mudd; Carey L Shive; Arnold Reynaldi; Soumya Panigrahi; Jacob D Estes; Claire Deleage; Carissa Lucero; Jodi Anderson; Timothy W Schacker; Miles P Davenport; Joseph M McCune; Peter W Hunt; Sulggi A Lee; Sergio Serrano-Villar; Robert L Debernardo; Jeffrey M Jacobson; David H Canaday; Rafick-Pierre Sekaly; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

3.  Distribution and evolution of T-cell receptor Vbeta repertoire on peripheral blood lymphocytes of newborn infants of human immunodeficiency virus (HIV)-infected mothers: differential display on CD4 and CD8 T cells and effect of HIV infection.

Authors:  William Borkowsky; Song-He Chen; Ilana Belitskaya-Levy
Journal:  Clin Vaccine Immunol       Date:  2007-07-25

4.  T-cell receptor Vβ repertoire of CD8+ T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil.

Authors:  Raquel Ferraz; Clarissa Ferreira Cunha; Maria Inês Pimentel; Marcelo Rosandiski Lyra; Armando Oliveira Schubach; Sérgio Coutinho Furtado de Mendonça; Alda Maria Da-Cruz; Alvaro Luiz Bertho
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-06-24       Impact factor: 2.743

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.